Aethlon Medical, Inc. (NASDAQ: AEMD) surged up 383.22% to $6.91 in exceptionally active trading, with roughly 80.0 million shares changing hands versus average daily volume…
NRx’s HOPE Therapeutics Prepares First Robotic TMS Deployment in Florida
Key Points NRx Pharmaceuticals’ HOPE Therapeutics subsidiary is preparing to deploy Zeta Surgical’s FDA-cleared robotic transcranial magnetic stimulation, or TMS, system in Florida clinics. HOPE…
BrainsWay Pilot Study Links Deep TMS to Depression Improvement in Early Alzheimer’s Patients
Key Points BrainsWay reported results from a 12-patient pilot study of Deep TMS in people with major depressive disorder and early-stage Alzheimer’s disease. After 36…
PRISM Mid-Day Movers: MedTech and New Energy are Today’s Leaders
bioAffinity Technologies (NASDAQ: BIAF) is up sharply again today, gaining roughly 56% intraday, following yesterday’s ~46% surge tied to news that CyPath® Lung will be…
Intelligent Bio Solutions Surges Nearly 29% as Drug Screening System Hits 98.2% Accuracy, Completing FDA 510(k) Data Package
Intelligent Bio Solutions Inc. (NASDAQ: INBS), a medical technology company delivering rapid, non-invasive testing solutions, announced results on September 1, 2026 from its latest Method…
PRISM Mid-Day Movers: Consumer Products and MedTech are Today’s Leaders.
GoPro (GPRO) is surging today, up roughly 44% as a wave of investor interest follows disclosure that YouTube creator Mark Fischbach—known as Markiplier—built an 8.5%…
Aethlon Medical (AEMD) is up 23.96% today to 2.69 from Thursday’s 2.17 close, although it has retreated from an intraday high of 3.29 after opening…
Biomerica Secures $2.23 Million and Launches Strategic Review to Unlock Shareholder Value
Key Points Biomerica agreed to sell 1,393,705 unregistered common shares at $1.60 per share, generating approximately $2.23 million in gross proceeds. The financing includes no…
Key Points Aurora acquired 100% of Internode Pharma and HAP Pharma through a wholly owned subsidiary. The company paid £2.1 million in cash at closing,…
Amylyx Pharmaceuticals (NASDAQ: AMLX) is rallying sharply today, up 49.42% to 32.02 from Monday’s 21.43 close after opening at 29.93. Shares have traded from 28.00…
Key Points AL001 data will be presented during a 10-minute oral session on September 29, 2026, at the ISMRM X-Nuclei MR Workshop. The completed Phase…
Key Points InspireMD expects potential FDA decisions in Q4 2026 for the CGuard Prime 80 cmsystem for transcarotid artery revascularization, or TCAR, and its original CGuard carotid artery…





